Normal vas deferens in fetuses with cystic fibrosis. 1997

D A Gaillard, and F Carré-Pigeon, and A Lallemand
Reproduction and Developmental Biology Department, UFR Medicine, Inserm U314, Reims, France.

OBJECTIVE Infertility in patients with cystic fibrosis has been attributed to the congenital bilateral absence of the vas deferens. We studied the vas deferens in cystic fibrosis fetuses to determine whether this condition could be related to primary developmental abnormalities or to secondary obstructions. METHODS Two cystic fibrosis male fetuses, with deltaF508+/+ and deltaF508/G542X genetic mutations, were examined after abortion at 12 and 18 weeks, respectively. The lumens of the vas deferens were measured using histological serial sections in the 2 cystic fibrosis fetuses and in 6 control fetuses. RESULTS The vas deferens of cystic fibrosis and control fetuses showed a similar development. The diameters of the lumens were smaller at the extremities than in the medial part of the duct in cystic fibrosis and in control fetuses. No epithelial necrosis, focal dilatation or fibrous stenosis could be detected at any age. Secretions were observed in the lumen of the vas deferens of the homozygous fetus, but no obstruction was detected. CONCLUSIONS The normal organogenesis of the vas deferens, the presence of secretions filling the lumen of the deltaF508 +/+ fetus and the high proportion of normal ducts reported in prepubertal male cystic fibrosis patients suggest a mechanism of luminal obstruction resulting in duct atrophy and infertility in male adults with cystic fibrosis. The term "atresia" or "inspissation" should be used in cases of congenital bilateral absence of the vas deferens associated with cystic fibrosis mutations, whereas the term "agenesis" should be used for cases of congenital bilateral absence of the vas deferens associated with urogenital abnormalities in which regional defects occur during organogenesis.

UI MeSH Term Description Entries
D008297 Male Males
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014649 Vas Deferens The excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct. Ductus Deferens,Deferens, Ductus,Deferens, Vas

Related Publications

D A Gaillard, and F Carré-Pigeon, and A Lallemand
September 1969, Lancet (London, England),
D A Gaillard, and F Carré-Pigeon, and A Lallemand
January 1969, The New England journal of medicine,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
September 1997, Actas urologicas espanolas,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
January 1975, Urology,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
February 2003, Minerva pediatrica,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
July 1995, Der Urologe. Ausg. A,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
July 1991, The New England journal of medicine,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
December 1969, Archives of pathology,
D A Gaillard, and F Carré-Pigeon, and A Lallemand
May 1992, Lancet (London, England),
D A Gaillard, and F Carré-Pigeon, and A Lallemand
February 2019, Mechanisms of development,
Copied contents to your clipboard!